Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy

BACKGROUND: People who inject drugs (PWID) constitute 60% of the approximately 5 million people in the U.S. infected with hepatitis C virus (HCV). Treatment of PWID is complex due to addiction, mental illness, poverty, homelessness, lack of positive social support, poor adherence-related skills, low...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Akiyama, Matthew J., Agyemang, Linda, Arnsten, Julia H., Heo, Moonseong, Norton, Brianna L., Schackman, Bruce R., Linas, Benjamin P., Litwin, Alain H.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5807730/
https://ncbi.nlm.nih.gov/pubmed/29426304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-018-2964-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados